LAURA STEWART: Open Payments
NPI 1831424761 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 33 payments from 10 companies in 2025. Trend: 2023 $277 · 2024 $166 · 2025 $638
Food & beverage: $547Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $201 |
| Sage Therapeutics, LLC | 9 | $151 |
| Boston Scientific Corporation | 2 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| MILLICENT US INC | 1 | $21 |
Products named: ZURZUVAE, Veozah, GEMTESA, Solyx SIS System, ACCRUFER, Bulkamid - Bulkamid Urethral Bulking Pack 2mL (OUS), Qelbree, ABRYSVO.
Industry payments across AL — which companies pay providers there.
